CN106490609A - 一种王枣子口含片及其生产方法 - Google Patents
一种王枣子口含片及其生产方法 Download PDFInfo
- Publication number
- CN106490609A CN106490609A CN201610891950.7A CN201610891950A CN106490609A CN 106490609 A CN106490609 A CN 106490609A CN 201610891950 A CN201610891950 A CN 201610891950A CN 106490609 A CN106490609 A CN 106490609A
- Authority
- CN
- China
- Prior art keywords
- benth
- parts
- isodon amethystoides
- wuet hsuen
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000554432 Isodon amethystoides Species 0.000 title claims abstract description 75
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 30
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 53
- 241000581835 Monodora junodii Species 0.000 claims abstract description 31
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 28
- 229920002472 Starch Polymers 0.000 claims abstract description 28
- 239000011734 sodium Substances 0.000 claims abstract description 28
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 28
- 239000008107 starch Substances 0.000 claims abstract description 28
- 235000019698 starch Nutrition 0.000 claims abstract description 28
- 241000628997 Flos Species 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 16
- 229920001353 Dextrin Polymers 0.000 claims abstract description 14
- 239000004375 Dextrin Substances 0.000 claims abstract description 14
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims abstract description 14
- 235000019425 dextrin Nutrition 0.000 claims abstract description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 13
- 229930006000 Sucrose Natural products 0.000 claims abstract description 13
- 239000005720 sucrose Substances 0.000 claims abstract description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 12
- 239000012467 final product Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000007605 air drying Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 239000000686 essence Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000005292 vacuum distillation Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 19
- 210000004185 liver Anatomy 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 210000002249 digestive system Anatomy 0.000 abstract description 2
- 238000010579 first pass effect Methods 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 210000002200 mouth mucosa Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 12
- 230000036541 health Effects 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 230000005784 autoimmunity Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002443 hepatoprotective effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 206010022000 influenza Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000004206 stomach function Effects 0.000 description 4
- 208000007882 Gastritis Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 3
- 201000008383 nephritis Diseases 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 208000003265 stomatitis Diseases 0.000 description 3
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 241001183967 Isodon Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- BAXVJERFBZODKZ-UHFFFAOYSA-N wangzaozin A Natural products C1CC(C2O)C(=C)C(=O)C32C(O)CC2C(C)(C)C(O)CCC2(C)C31 BAXVJERFBZODKZ-UHFFFAOYSA-N 0.000 description 1
- BAXVJERFBZODKZ-KYCDYYFSSA-N wangzaozin a Chemical compound C1C[C@H]([C@H]2O)C(=C)C(=O)[C@@]32[C@H](O)C[C@@H]2C(C)(C)[C@@H](O)CC[C@@]2(C)C31 BAXVJERFBZODKZ-KYCDYYFSSA-N 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种王枣子口含片及其生产方法,由以下重量份的原料制成:王枣子提取物10‑15份,青苹果稠膏38‑45份,亳菊花提取物5‑8份,糊精15‑18份,药用淀粉15‑18份,羧甲基淀粉钠1‑2份,蔗糖1‑2份,香精钠0.3‑0.4份,硬脂酸镁4‑6份,蒸馏水适量。本发明的口含片具有一定的保健功效,可使王枣子提取物、青苹果稠膏和亳菊花提取物药效成分通过口腔粘膜直接被吸收,避免了有效成分通过消化系统的吸收产生的肝脏首过效应,提高了药效成分的利用率。
Description
技术领域
本发明涉及食品加工技术领域,特别是一种王枣子口含片及其生产方法。
背景技术
口含片指含于口腔内缓慢溶解的压制片,能对口腔及咽部产生持久的药效,用于局部的消炎、消毒等,如草珊瑚含片。含化药片或药丸治疗咽炎具有以下优点:1、直接作用在咽部。具有抑菌、杀菌、消炎、消肿、稀化粘稠分泌物、收敛、刺激粘膜分泌等作用。2、由于缓慢的含化,使药物能较长时间停留在咽部,持续发挥药效。3、对于缓解咽干、咽痛等不适感觉见效快。4、具有抑菌、杀菌、消炎、消肿、稀化粘稠分泌物、收敛、刺激粘膜分泌等作用。口含片其特点主要是通过舌下和口腔颊面粘膜吸收,具有吸收快、起效迅速,临床上主要用于治疗口腔、咽喉部疾病。
王枣子生长在安徽省宿州市北部符离、夹沟、曹村、国家森林公园皇藏峪一带山区,是野生药食两用草本植物,具有一定的消炎、解毒、抗衰、抗疲劳、护肝和胃、醒酒保健、提高自身免疫力等作用,被誉为“天然植物抗生素”。王枣子为唇形科香茶菜属植物,宿州(原宿县)医院用王枣子治疗肺脓疡疗效显著。从王枣子叶乙醇提取物的中性部份分得七种结品成分,其中王枣子甲素为无色针品,为一新的四环二菇。《宿州志》《宿县志》记载,“王枣子生长在宿县北部符离、夹沟、曹村、国家森林公园黄藏峪一带山区,是野生药食两用植物”。民间习惯用于治疗各种疮疖、毒疮、肿瘤、肺结核、肺脓疡、老慢支、肾炎、咽炎、感冒发烧、乙肝、牛皮癣和毒蛇咬伤等多种疾病。具有抗菌消炎、抗肿瘤、保肝、抗氧化、保护心血管、抑制血小板凝聚,活血化瘀、整肠健胃、止咳平喘、退烧解毒等功效,故有“是疮不是疮,三碗王枣子汤,天天喝一碗,身体保健康”的民间谚语,被民间誉为“神奇的草药”。该草药多年来一直没有得到有效的保护利用和开发,现已濒临灭绝,后经建立了种植基地,仿野生种植,保种20多年,王枣子资源得到了一定程度的保护。上海中医大学、苏州大学、上海市肺科医院、上海华山医院等单位合作对王枣子全草进行有效成份提取分离和动物体内外药理、药效、药学、毒理学、药代动力学等相关领域的临床前研究,实验证明:王枣子是治疗自身免疫性疾病的良好天然药物,可以替代西药激素类、免疫抑制剂药物和抗菌素,且无西药的毒副作用。常饮王枣子茶不仅清心爽肺,具有一定的消炎、解毒、抗衰、抗疲劳、护肝和胃、醒酒保健、提高自身免疫力等作用,尤其对感冒、发烧、口腔炎、咽炎、支气管炎、肺炎、胃炎、肠炎、肾炎、前列腺炎、妇科炎症及肿瘤、疑难杂症等效果明显。它具有清咽排毒、抑制肿瘤,舒胃健脾、健身延年,促进人体新陈代谢等独特功效。对雾霾、pm2.5、沙尘暴、汽车尾气、工业粉尘、化工污染、室内装潢的受害人群,对吸入的烟、尘、废气、毒素、细菌等具有及时清洗的作用,可以减轻毒害,是理想的原生态茶饮品。
王枣子生长在安徽省宿州市北部药食两用草本植物,具有一定的消炎、解毒、抗衰、抗疲劳、护肝和胃、醒酒保健、提高自身免疫力等作用,被誉为“天然植物抗生素”。随着人们生活水平的提高和饮食保健意识的增强,进一步开发王枣子保健品成为食品企业一大课题,王枣子口含片就是在这一大背景下开发的一种以王枣子提取物加青苹果稠膏、亳菊花提取物加工而成的保健含片。
发明内容
本发明的目的是克服现有技术的不足,提供一种王枣子口含片,具有一定的保健功效。
为了实现上述目的,本发明采用如下技术方案:
一种王枣子口含片,由以下重量份的原料制成:王枣子提取物10-15份,青苹果稠膏38-45份,亳菊花提取物5-8份,糊精15-18份,药用淀粉15-18份,羧甲基淀粉钠1-2份,蔗糖1-2份,香精钠0.3-0.4份,硬脂酸镁4-6份,蒸馏水适量。
优选地,所述的王枣子口含片,由以下重量份的原料制成:王枣子提取物12份,青苹果稠膏40份,亳菊花提取物7份,糊精16份,药用淀粉17份,羧甲基淀粉钠2份,蔗糖1份,香精钠0.3份,硬脂酸镁4.7份,蒸馏水适量。
所述王枣子提取物由以下方法制备:将王枣子清洗干净,烘干,碾碎,过80目的筛网得王枣子粉末待用;向王枣子粉末中加入8倍体积的蒸馏水,加热至液体微沸状态提取2小时,然后使用5层纱布过滤两次得到王枣子提取液,再将王枣子提取液转移至旋转蒸发仪上减压蒸馏至稠膏状,烘箱内60℃鼓风干燥后研磨成粉即得王枣子提取物。
所述亳菊花提取物由以下方法制备:将亳菊花清洗干净,烘干,碾碎,过80目的筛网得亳菊花粉末待用;向亳菊花粉末中加入8倍体积的蒸馏水,加热至液体微沸状态提取2小时,然后使用5层纱布过滤两次得到亳菊花提取液,再将亳菊花提取液转移至旋转蒸发仪上减压蒸馏至稠膏状,烘箱内60℃鼓风干燥后研磨成粉即得亳菊花提取物。
所述的青苹果稠膏由以下方法制备:将青苹果去皮后,利用果蔬破碎机将去皮的青苹果绞碎至稠膏状,置烘箱内60℃鼓风干燥后研磨成粉即得青苹果稠膏。
本发明的王枣子口含片可以按照本领域普通技术人员熟知的方法制备的,优选以下制备方法:将王枣子提取物、青苹果稠膏、亳菊花提取物研碎,使之细度达到350-400目,然后与糊精、药用淀粉、羧甲基淀粉钠、蔗糖、香精钠、硬脂酸镁混合,用水均匀润湿,将润湿后的混合物过筛并干燥,再过筛,整粒,将此混合物压片,每片重200mg,提取物成分含量为100-130mg。
本发明所述重量份可以是μg、mg、g、kg等医药领域公知的质量单位。
本发明涉及的保健型口含片的剂量以单元剂型中存在的量计算,在单元剂型中本发明涉及的王枣子提取物、青苹果稠膏和亳菊花提取物总含量为100-130mg(口含片重量为200mg)。
成人服用本发明所述保健型王枣子口含片的量,每日为600-1000mg,分6-8次服用。
王枣子,是野生药食两用草本植物,是治疗自身免疫性疾病的良好天然药物,可以替代西药激素类、免疫抑制剂药物和抗菌素,且无西药的毒副作用。常饮王枣子茶不仅清心爽肺,具有一定的消炎、解毒、抗衰、抗疲劳、护肝和胃、醒酒保健、提高自身免疫力等作用,尤其对感冒、发烧、口腔炎、咽炎、支气管炎、肺炎、胃炎、肠炎、肾炎、前列腺炎、妇科炎症及肿瘤、疑难杂症等效果明显。它具有清咽排毒、抑制肿瘤,舒胃健脾、健身延年,促进人体新陈代谢等独特功效,是理想的原生态保健药食两用药材。
青苹果,含有大量的维生素、矿物质和丰富的膳食纤维,特别是果胶等成分,除了具有一般苹果之补心益气、益胃健脾等功效外,其止泻效果尤佳,慢性腹泻、神经性结肠炎、小儿腹泻患者可经常食用。青苹果养肝解毒,对抗抑郁症,适合年轻人食用,还可促进牙齿和骨骼生长,防止牙床出血。
亳菊花,是药用菊科植物,在诸多产地所产的药用菊花中,被公认为地道药材的为亳菊、滁菊、贡菊和杭菊,据《中华大辞典》载:“白菊主产安徽亳县,称亳菊,品质最佳”,具有散风清热,平肝明日。用于风热感冒,头痛眩晕,目赤肿痛,眼目昏花。
与已有技术相比,本发明的有益效果如下:
本发明的口含片可使王枣子提取物、青苹果稠膏和亳菊花提取物药效成分通过口腔粘膜直接被吸收,避免了有效成分通过消化系统的吸收产生的肝脏首过效应,提高了药效成分的利用率。本发明的王枣子口含片具有一定的保健功效,具有散风清热、消炎解毒、醒酒、补心益气的功效,可以用于治疗感冒、口腔炎、胃炎、咽炎、腹泻、牙床出血、头痛眩晕等症状。
具体实施方式
以下结合实施例对本发明作进一步的说明,但本发明不仅限于这些实施例,在未脱离本发明宗旨的前提下,所作的任何改进均落在本发明的保护范围之内。
首先,自市场购买或按照现有技术获得:
王枣子、青苹果、亳菊花、糊精、药用淀粉、羧甲基淀粉钠、蔗糖、香精钠、硬脂酸镁、蒸馏水。
接着,通过以下方法制得王枣子提取物、亳菊花提取物和青苹果稠膏:
将王枣子清洗干净,烘干,碾碎,过80目的筛网得王枣子粉末待用;向王枣子粉末中加入8倍体积的蒸馏水,加热至液体微沸状态提取2小时,然后使用5层纱布过滤两次得到王枣子提取液,再将王枣子提取液转移至旋转蒸发仪上减压蒸馏至稠膏状,烘箱内60℃鼓风干燥后研磨成粉即得王枣子提取物。
将亳菊花清洗干净,烘干,碾碎,过80目的筛网得亳菊花粉末待用;向亳菊花粉末中加入8倍体积的蒸馏水,加热至液体微沸状态提取2小时,然后使用5层纱布过滤两次得到亳菊花提取液,再将亳菊花提取液转移至旋转蒸发仪上减压蒸馏至稠膏状,烘箱内60℃鼓风干燥后研磨成粉即得亳菊花提取物。
将青苹果去皮后,利用果蔬破碎机将去皮的青苹果绞碎至稠膏状,置烘箱内60℃鼓风干燥后研磨成粉即得青苹果稠膏。
然后,
实施例1:
一种王枣子口含片,原料配比如下:王枣子提取物10份,青苹果稠膏38份,亳菊花提取物5.7份,糊精18份,药用淀粉18份,羧甲基淀粉钠2份,蔗糖2份,香精钠0.3份,硬脂酸镁6份,蒸馏水适量。
所述的王枣子口含片的生产方法:将王枣子提取物、青苹果稠膏、亳菊花提取物研碎,使之细度达到350-400目,然后与糊精、药用淀粉、羧甲基淀粉钠、蔗糖、香精钠、硬脂酸镁混合,用适量水均匀润湿,将润湿后的混合物过筛并干燥,再过筛,整粒,将此混合物压片,每片重200mg,提取物成分含量约为107mg。
实施例2:
一种王枣子口含片,原料配比如下:王枣子提取物15份,青苹果稠膏40份,亳菊花提取物6.7份,糊精15份,药用淀粉15份,羧甲基淀粉钠2份,蔗糖2份,香精钠0.3份,硬脂酸镁4份,蒸馏水适量。
所述的王枣子口含片的生产方法,将王枣子提取物、青苹果稠膏、亳菊花提取物研碎,使之细度达到350-400目,然后与糊精、药用淀粉、羧甲基淀粉钠、蔗糖、香精钠、硬脂酸镁混合,用适量水均匀润湿,将润湿后的混合物过筛并干燥,再过筛,整粒,将此混合物压片,每片重200mg,提取物成分含量约为123mg。
实施例3:
一种王枣子口含片,原料配比如下:王枣子提取物13份,青苹果稠膏41份,亳菊花提取物7.7份,糊精15份,药用淀粉15份,羧甲基淀粉钠2份,蔗糖2份,香精钠0.3份,硬脂酸镁4份,蒸馏水适量。
所述的王枣子口含片的生产方法:将王枣子提取物、青苹果稠膏、亳菊花提取物研碎,使之细度达到350-400目,然后与糊精、药用淀粉、羧甲基淀粉钠、蔗糖、香精钠、硬脂酸镁混合,用适量水均匀润湿,将润湿后的混合物过筛并干燥,再过筛,整粒,将此混合物压片,每片重200mg,提取物成分含量为约为123mg。
Claims (6)
1.一种王枣子口含片,其特征在于:由以下重量份的原料制成:王枣子提取物10-15份,青苹果稠膏38-45份,亳菊花提取物5-8份,糊精15-18份,药用淀粉15-18份,羧甲基淀粉钠1-2份,蔗糖1-2份,香精钠0.3-0.4份,硬脂酸镁4-6份,蒸馏水适量。
2.根据权利要求1所述的王枣子口含片,其特征在于:由以下重量份的原料制成:王枣子提取物12份,青苹果稠膏40份,亳菊花提取物7份,糊精16份,药用淀粉17份,羧甲基淀粉钠2份,蔗糖1份,香精钠0.3份,硬脂酸镁4.7份,蒸馏水适量。
3.根据权利要求1所述的王枣子口含片,其特征在于:所述王枣子提取物由以下方法制备:将王枣子清洗干净,烘干,碾碎,过80目的筛网得王枣子粉末待用;向王枣子粉末中加入8倍体积的蒸馏水,加热至液体微沸状态提取2小时,然后使用5层纱布过滤两次得到王枣子提取液,再将王枣子提取液转移至旋转蒸发仪上减压蒸馏至稠膏状,烘箱内60℃鼓风干燥后研磨成粉即得王枣子提取物。
4.根据权利要求1所述的王枣子口含片,其特征在于:所述亳菊花提取物由以下方法制备:将亳菊花清洗干净,烘干,碾碎,过80目的筛网得亳菊花粉末待用;向亳菊花粉末中加入8倍体积的蒸馏水,加热至液体微沸状态提取2小时,然后使用5层纱布过滤两次得到亳菊花提取液,再将亳菊花提取液转移至旋转蒸发仪上减压蒸馏至稠膏状,烘箱内60℃鼓风干燥后研磨成粉即得亳菊花提取物。
5.根据权利要求1所述的王枣子口含片,其特征在于:所述的青苹果稠膏由以下方法制备:将青苹果去皮后,利用果蔬破碎机将去皮的青苹果绞碎至稠膏状,置烘箱内60℃鼓风干燥后研磨成粉即得青苹果稠膏。
6.根据权利要求1-5中任一项所述的王枣子口含片的生产方法,其特征在于:将王枣子提取物、青苹果稠膏、亳菊花提取物研碎,使之细度达到350-400目,然后与糊精、药用淀粉、羧甲基淀粉钠、蔗糖、香精钠、硬脂酸镁混合,用适量水均匀润湿,将润湿后的混合物过筛并干燥,再过筛,整粒,将此混合物压片,即得王枣子口含片。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610891950.7A CN106490609A (zh) | 2016-10-13 | 2016-10-13 | 一种王枣子口含片及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610891950.7A CN106490609A (zh) | 2016-10-13 | 2016-10-13 | 一种王枣子口含片及其生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106490609A true CN106490609A (zh) | 2017-03-15 |
Family
ID=58294948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610891950.7A Pending CN106490609A (zh) | 2016-10-13 | 2016-10-13 | 一种王枣子口含片及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106490609A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111888389A (zh) * | 2020-08-28 | 2020-11-06 | 宿州绿源中医药科技有限公司 | 一种用于治疗间质性肺炎的王枣子萃取物及其制备方法 |
BE1028983B1 (fr) * | 2020-12-31 | 2022-08-02 | Laboratoires Pharmaceutiques Trenker Farm Laboratoria Trenker | Procédé de fabrication de comprimés nus et sécables de compléments alimentaires et comprimés ainsi obtenus |
CN114903949A (zh) * | 2022-06-08 | 2022-08-16 | 宿州市王枣子种植专业合作社 | 一种用于治疗肺结节的王枣子提取物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524551A (zh) * | 2003-02-27 | 2004-09-01 | 宿州绿源中医药科技有限公司 | 中草药香茶菜和王枣子的医药新用途 |
CN1718225A (zh) * | 2004-07-07 | 2006-01-11 | 庞国 | 治疗肝功能损害的复方中药制剂及其制备 |
CN103610039A (zh) * | 2013-11-10 | 2014-03-05 | 刘三保 | 一种香茶百合保健锅巴 |
CN103766908A (zh) * | 2014-03-03 | 2014-05-07 | 安徽科技学院 | 一种保健型滁菊口含片及其生产方法 |
CN104173592A (zh) * | 2014-08-25 | 2014-12-03 | 宿州绿源中医药科技有限公司 | 一种王枣子中药茶饮其制备方法 |
-
2016
- 2016-10-13 CN CN201610891950.7A patent/CN106490609A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524551A (zh) * | 2003-02-27 | 2004-09-01 | 宿州绿源中医药科技有限公司 | 中草药香茶菜和王枣子的医药新用途 |
CN1718225A (zh) * | 2004-07-07 | 2006-01-11 | 庞国 | 治疗肝功能损害的复方中药制剂及其制备 |
CN103610039A (zh) * | 2013-11-10 | 2014-03-05 | 刘三保 | 一种香茶百合保健锅巴 |
CN103766908A (zh) * | 2014-03-03 | 2014-05-07 | 安徽科技学院 | 一种保健型滁菊口含片及其生产方法 |
CN104173592A (zh) * | 2014-08-25 | 2014-12-03 | 宿州绿源中医药科技有限公司 | 一种王枣子中药茶饮其制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111888389A (zh) * | 2020-08-28 | 2020-11-06 | 宿州绿源中医药科技有限公司 | 一种用于治疗间质性肺炎的王枣子萃取物及其制备方法 |
BE1028983B1 (fr) * | 2020-12-31 | 2022-08-02 | Laboratoires Pharmaceutiques Trenker Farm Laboratoria Trenker | Procédé de fabrication de comprimés nus et sécables de compléments alimentaires et comprimés ainsi obtenus |
BE1028923B1 (fr) * | 2020-12-31 | 2022-11-21 | Laboratoires Pharmaceutiques Trenker Farm Laboratoria Trenker | Procédé de fabrication de comprimés faciles à avaler, nus de pelliculage et sécables de compléments alimentaires et comprimés ainsi obtenus |
CN114903949A (zh) * | 2022-06-08 | 2022-08-16 | 宿州市王枣子种植专业合作社 | 一种用于治疗肺结节的王枣子提取物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101518580B (zh) | 清热解毒的药物组合物及其制备方法和用途 | |
CN103815111B (zh) | 一种保健型滁菊口香糖及其生产方法 | |
CN1757317A (zh) | 罗汉果片及其制备工艺 | |
CN103766908A (zh) | 一种保健型滁菊口含片及其生产方法 | |
CN106492073A (zh) | 一种具有降尿酸功效的中药组合物及其制备方法和应用 | |
CN101129826B (zh) | 中药保健枕 | |
CN106490609A (zh) | 一种王枣子口含片及其生产方法 | |
CN101507800A (zh) | 金线莲和南瓜复合降血糖保健品及其制备方法 | |
CN102671097A (zh) | 一种内服治疗冠心病的中药组合物 | |
CN104224976B (zh) | 一种禹州漏芦口含片及其生产方法 | |
CN102973863A (zh) | 一种小儿止咳中草药组合物及其制备方法 | |
CN102335358A (zh) | 一种治疗心律失常的中药制剂 | |
CN107375509B (zh) | 一种用于提高免疫力的保健食品 | |
CN1416865A (zh) | 用于治疗口臭及病因的药物制剂 | |
CN106361805A (zh) | 一种具有清咽利喉功效的中药组合物及其制备方法和制剂 | |
CN106615528A (zh) | 一种养阴清肺功能糖果及其制备方法 | |
CN106359824A (zh) | 一种王枣子口香糖及其生产方法 | |
CN106511491A (zh) | 一种组合物及其制备方法、应用、制剂 | |
CN1055846C (zh) | 一种清音利咽润喉保健制品及其生产工艺 | |
CN1203881C (zh) | 治疗感冒、流行性感冒及并发症的药剂及其制备工艺 | |
CN108143944A (zh) | 一种治疗伤风的中药组合物 | |
CN106309589A (zh) | 一种治疗皮肤瘙痒症的药物及其制备方法 | |
CN1569181A (zh) | 防治吸烟及空气污染危害的中药及其制备方法 | |
CN105596581A (zh) | 一种用于治疗人乳头瘤病毒感染的药物制剂及其制备方法和应用 | |
CN105125985A (zh) | 一种治疗老年慢性支气管炎的中西药复方制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170315 |